<i>CREBBP</i> histone acetyltransferase domain mutations predict response to mTOR inhibition in relapsed/refractory follicular lymphomaEmil Kumar, Jessica Okosun, Findlay Bewicke‐Copley et al.|British Journal of Haematology|2024Cited by 1